13 Results for "

steroid 5α-reductase

" in MedChemExpress (MCE) Product Catalog:
Products (13)

13 Results for "steroid 5α-reductase" in MCE Product Catalog:

Cat. No.: HY-E70558
Target:  

5 alpha Reductase

Research Areas:  

Metabolic Disease

5α-reductase, Rat (Sprague-Dawley) Liver is an enzyme involved in steroid metabolism and participates in the androgen metabolic pathway. 5α-reductase, Rat (Sprague-Dawley) Liver catalyzes the conversion of testosterone to 5α-dihydrotestosterone (DHT). DHT plays important roles in the development of male sex organs, hair growth, prostate function, and other aspects .
loading...
    loading...
Cat. No.: HY-103245
CAS No.: 188589-66-4
Purity:  99.64%
Target:  

Androgen Receptor

Research Areas:  

Cancer

Cl-4AS-1, a potent steroidal androgen receptor (AR) agonist (IC50 = 12 nM), is also an inhibitor of 5α-reductase types I and II (IC50 = 6 and 10 nM, respectively) .
loading...
    loading...
Cat. No.: HY-152094
CAS No.: 2279077-93-7
Purity:  99.82%
Target:  

5 alpha Reductase

Research Areas:  

Endocrinology

SRD5A1-IN-1 (Compound 4) is a competitive and covalent steroid 5α-reductase type 1 (SRD5A1) inhibitor with an IC50 of 1.44 µM. SRD5A1-IN-1 modulates SRD5A1 function, leading to a lower level of dihydrotestosterone (DHT) production and SRD5A1 protein suppression .
loading...
    loading...
Cat. No.: HY-123323
CAS No.: 134067-56-4
Target:  

5 alpha Reductase

Research Areas:  

Endocrinology

MK-0434 is an orally active steroid 5α-reductase inhibitor. MK-0434 specifically inhibits steroid 5α-reductase, thereby reducing the level of dihydrotestosterone (DHT) in the body. MK-0434 can be used in the study of benign prostatic hyperplasia .
loading...
    loading...
Cat. No.: HY-19144
CAS No.: 119347-91-0
Target:  

5 alpha Reductase

Research Areas:  

Others

ONO-3805 is an early lead compound of a non-steroidal 5α-reductase inhibitor, used to inhibit the conversion of testosterone to dihydrotestosterone, with potential effects in inhibiting benign prostatic hyperplasia.
loading...
    loading...
Cat. No.: HY-106129
CAS No.: 176975-26-1
Synonyms: LY 320236
Target:  

5 alpha Reductase

Research Areas:  

Endocrinology Cancer

Izonsteride (Compound LY320236) is an inhibitor of 5α-reductase (IC50 = 11.6 nM for type I; 7.37 nM for type II). LY320236 inhibits the activity of steroid 5α-reductase, preventing the conversion of testosterone (T) to dihydrotestosterone (DHT). LY320236 can significantly inhibit the growth of LNCaP tumors in thymic mice without exhibiting obvious host toxicity .
loading...
    loading...
Cat. No.: HY-106363
CAS No.: 103497-68-3
Synonyms: L 654066
Target:  

5 alpha Reductase

Research Areas:  

Others

MK-0963 is a steroidal 5α-reductase inhibitor. MK-0963 reduces serum dihydrotestosterone (DHT) concentrations in a dose-dependent manner. MK-0963 can be used for the study of dihydrotestosterone-related diseases such as benign prostate hyperplasia (BPH) .
loading...
    loading...
Cat. No.: HY-106614
CAS No.: 105149-00-6
Research Areas:  

Endocrinology

Osaterone acetate is an orally active steroid anti-androgen agent, mainly used for benign prostatic hyperplasia (BPH) in dogs. Osaterone acetate competitively antagonizes androgen receptor and inhibits 5α-reductase, reducing the concentration of dihydrotestosterone (DHT) while blocking the growth-stimulating effects of testosterone and DHT on prostate cells. Osaterone acetate can rapidly alleviate the symptoms of BPH in dogs without affecting the fertility of breeding dogs .
loading...
    loading...
Cat. No.: HY-B1734
CAS No.: 979-02-2
Synonyms: 16-DPA
16-Dehydropregnenolone acetate (16-DPA), a sterols compound, is an orally active 17α-hydroxylase and 5α-reductase inhibitor. 16-Dehydropregnenolone is also a potent bile acid receptor (BAR)/farnesoid X receptor (FXR) antagonist. 16-Dehydropregnenolone hypolipidemic and anticancer effects. 16-Dehydropregnenolone acetate (16-DPA) is the drug intermediate that can be used for synthesis of Dexamethasone (HY-14648) and related other steroidal pharmacophores .
loading...
    loading...
Cat. No.: HY-175719
Target:  

5 alpha Reductase

Research Areas:  

Endocrinology

SRD5A1-IN-2 is a inhibitor of steroid 5α-reductase type-1 (SRD5A1), with an IC50 of 8.5 μM. SRD5A1-IN-2 downregulates SRD5A1 protein expression in HaCaT cells. SRD5A1-IN-2 reduces dihydrotestosterone (DHT) production in HaCaT cells. SRD5A1-IN-2 can be used for the study of androgen-related conditions such as androgenetic alopecia (AGA) .
loading...
    loading...
Cat. No.: HY-133949
CAS No.: 82073-91-4
Target:  

5 alpha Reductase

Research Areas:  

Endocrinology

8,11-Eicosadiynoic acid, an unsaturated fatty acid, is a steroid 5α-reductase inhibitor. 8,11-Eicosadiynoic acid can be used for the research of acne .
loading...
    loading...
Cat. No.: HY-19284
CAS No.: 146939-64-2
Synonyms: FK 687; TF 505
Target:  

5 alpha Reductase

Research Areas:  

Endocrinology

FR-146687 (FK 687) is a selective and orally active 5α-reductase inhibitor with IC50s of 1.7 nM and 4.6 nM for rat and human 5α-reductases, respectively. FR-146687 shows no inhibitory effects on other steroid oxidoreductases .
loading...
    loading...
Cat. No.: HY-103245R
CAS No.: 188589-66-4
Research Areas:  

Cancer

Cl-4AS-1 (Standard) is the analytical standard of Cl-4AS-1 (HY-103245). This product is intended for research and analytical applications. Cl-4AS-1, a potent steroidal androgen receptor (AR) agonist (IC50 = 12 nM), is also an inhibitor of 5α-reductase types I and II (IC50 = 6 and 10 nM, respectively) .
loading...
    loading...
  • 1